{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P35968",
      "entity_text" : "VEGF-R2",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1070" ]
    }
  },
  "verbose_text" : "Although the mechanism of dopamine action was not established in this pioneer report, it is now known from studies in rodents and humans that dopamine agonists are potent inhibitors of VEGF mediated increased vascular permeability by inhibition of VEGF-R2 phosphorylation and specifically act at the ovarian level.",
  "reading_complete" : "2020-08-04T18:06:40Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T18:03:06Z",
  "trigger" : "phosphorylation",
  "evidence" : [ "VEGF-R2 phosphorylation" ],
  "pmc_id" : "2839910",
  "score" : 0
}